Teracero Pharma annonce avoir reçu la première autorisation au Canada en vertu de l'arrêté d’urgence du ministre de la Santé pour un test sérologique rapide pour la COVID-19
17 mars 2021 14h00 HE
|
Teracero Pharma Inc.
Le test NADAL COVID-19 IgG/IgM de nal von Minden GmbH est très sensible et spécifique aux anticorps contre le SRAS-CoV-2, ne nécessite aucune formation particulière et fournit des résultats en 10...
A new stage in COVID-19 testing – Teracero Pharma reports receiving the first authorization for a COVID-19 serology rapid test under the Minister of Health’s Interim Order
17 mars 2021 14h00 HE
|
Teracero Pharma Inc.
nal von Minden GmbH’s NADAL COVID-19 IgG/IgM Test is highly sensitive and specific to antibodies against SARS-CoV-2, requires no special training, and can provide results within 10 minutes MONTREAL,...
Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test
16 févr. 2021 05h30 HE
|
Luminostics
Luminostics’s Clip COVID Rapid Antigen Test uses a smartphone-based analyzer to obtain results in 30 minutes from nasal swabs in decentralized settingsClip COVID’s emergency use authorization (EUA) in...
Precipio Launches COVID-19 Antibody Testing at Point-of-Care
28 janv. 2021 09h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA...
Global Antigen Rapid Test Kit Market, Forecast & Opportunities, 2026 - Over-the-counter (OTC) Rapid Test Kit v/s Professional Rapid Test Kit
28 janv. 2021 05h28 HE
|
Research and Markets
Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Rapid Test Kit Market by Type (Rapid Antigen Test v/s Rapid Antibody Test), by Product Type (Over-the-counter (OTC) Rapid Test Kit v/s...
Global Immunoassay Markets, Strategies and Trends Report 2021: Multiplex and Point of Care Market Analysis & Forecasts 2019-2023
25 janv. 2021 04h58 HE
|
Research and Markets
Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market...
Global WholeHealth Partners Corp (GWHP-OTC) to Announce that Global is Now Selling Access Bio Antigen Test
21 janv. 2021 06h30 HE
|
Global WholeHealth Partners Corp.
Antigen Testing is Essential to Keep the Fight Against CoViD19 SARS 2 SAN CLEMENTE, CA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners...
Global WholeHealth Partners Corp (GWHP-OTC) to Announce that the Antibody Test Kits Offered by Global Can Detect the Mutated COVID-19 Strain
20 janv. 2021 06h30 HE
|
Global WholeHealth Partners Corp.
Global's Antibody Test Can Detect the New CoViD 19 SARS 2 Strain SAN CLEMENTE, CA, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners Corp...
iXensor to close the loop of COVID-19 outbreak prevention with the fully digitalized rapid antigen test and an encrypted mobile pass
17 déc. 2020 02h35 HE
|
iXensor Co., LTD.
TAIPEI, TAIWAN and PALO ALTO, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its...
Immunoassays - Worldwide Industry Analysis (2019-2023) with Profiles of 44 Companies
26 août 2020 10h23 HE
|
Research and Markets
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market...